Eaton Vance Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $48.2M | Buy |
262,238
+95
| +0% | +$18.9K | 0.07% | 269 |
|
|
2022
Q2 | $44.1M | Sell |
262,143
-4,516
| -2% | -$970K | 0.06% | 293 |
|
|
2022
Q1 | $66.8M | Buy |
266,659
+6,896
| +3% | +$1.73M | 0.08% | 254 |
|
|
2021
Q4 | $66.7M | Buy |
259,763
+17,383
| +7% | +$4.25M | 0.08% | 239 |
|
|
2021
Q3 | $57.7M | Buy |
242,380
+3,610
| +2% | +$883K | 0.08% | 236 |
|
|
2021
Q2 | $49.4M | Buy |
238,770
+3,430
| +1% | +$699K | 0.07% | 277 |
|
|
2021
Q1 | $44.3M | Buy |
235,340
+1,170
| +0.5% | +$206K | 0.07% | 286 |
|
|
2020
Q4 | $38.5M | Buy |
234,170
+133
| +0.1% | +$19.4K | 0.06% | 293 |
|
|
2020
Q3 | $29.2M | Buy |
234,037
+80
| +0% | +$9.9K | 0.05% | 300 |
|
|
2020
Q2 | $22.7M | Sell |
233,957
-49
| -0% | -$5.09K | 0.05% | 316 |
|
|
2020
Q1 | $21M | Buy |
234,006
+520
| +0.2% | +$67.3K | 0.05% | 294 |
|
|
2019
Q4 | $34.5M | Buy |
233,486
+73
| +0% | +$9.8K | 0.07% | 248 |
|
|
2019
Q3 | $28.1M | Buy |
233,413
+6
| +0% | +$775 | 0.06% | 255 |
|
|
2019
Q2 | $31.6M | Buy |
233,407
+8,087
| +4% | +$1.02M | 0.07% | 249 |
|
|
2019
Q1 | $29.4M | Buy |
225,320
+46,536
| +26% | +$6.25M | 0.07% | 249 |
|
|
2018
Q4 | $22.3M | Buy |
178,784
+7,185
| +4% | +$964K | 0.06% | 258 |
|
|
2018
Q3 | $23.9M | Hold |
171,599
| – | – | 0.05% | 263 |
|
|
2018
Q2 | $17.6M | Sell |
171,599
-171,575
| -50% | -$17.4M | 0.04% | 292 |
|
|
2018
Q1 | $33.3M | Sell |
343,174
-4,373
| -1% | -$424K | 0.04% | 302 |
|
|
2017
Q4 | $30.5M | Sell |
347,547
-28,505
| -8% | -$2.29M | 0.07% | 227 |
|
|
2017
Q3 | $29.9M | Hold |
376,052
| – | – | 0.08% | 215 |
|
|
2017
Q2 | $32.8M | Hold |
376,052
| – | – | 0.09% | 204 |
|
|
2017
Q1 | $33.5M | Sell |
376,052
-80,448
| -18% | -$6.71M | 0.09% | 195 |
|
|
2016
Q4 | $33.8M | Buy |
456,500
+41
| +0% | +$3.07K | 0.1% | 183 |
|
|
2016
Q3 | $34.5M | Sell |
456,459
-404,476
| -47% | -$31M | 0.1% | 178 |
|
|
2016
Q2 | $66.3M | Buy |
860,935
+715,821
| +493% | +$56.5M | 0.19% | 119 |
|
|
2016
Q1 | $11.3M | Hold |
145,114
| – | – | 0.03% | 302 |
|
|
2015
Q4 | $9.81M | Hold |
145,114
| – | – | 0.03% | 325 |
|
|
2015
Q3 | $11.2M | Hold |
145,114
| – | – | 0.03% | 303 |
|
|
2015
Q2 | $13.2M | Sell |
145,114
-1,842
| -1% | -$148K | 0.04% | 279 |
|
|
2015
Q1 | $11.1M | Sell |
146,956
-1
| -0% | -$72 | 0.03% | 307 |
|
|
2014
Q4 | $10.8M | Sell |
146,957
-25
| -0% | -$1.76K | 0.03% | 302 |
|
|
2014
Q3 | $10.4M | Sell |
146,982
-80
| -0.1% | -$5.29K | 0.03% | 305 |
|
|
2014
Q2 | $8.29M | Buy |
147,062
+59,878
| +69% | +$3.16M | 0.02% | 319 |
|
|
2014
Q1 | $4.58M | Buy |
87,184
+17
| +0% | +$846 | 0.01% | 405 |
|
|
2013
Q4 | $4.16M | Buy |
+87,167
| New | +$4.03M | 0.01% | 421 |
|
Other funds holding HCA
Eaton Vance Management's HCA Position: Q3 2022 in Review
Eaton Vance Management increased its HCA Healthcare (HCA) stake by 0.04% in Q3 2022, buying an estimated $18.9K and bringing the position to 262,238 shares worth $48.2M. The position accounts for 0.07% of the portfolio, ranked #269.
Eaton Vance Management first reported a position in HCA in Q4 2013 and has held it in 36 quarters since. The position peaked at $66.8M in Q1 2022. 867 funds tracked by Wall St. Rank hold HCA as of Q3 2022.
- Eaton Vance Management held 262,238 shares of HCA Healthcare worth $48.2M as of Q3 2022.
- Eaton Vance Management bought 95 HCA Healthcare shares in Q3 2022, an estimated $18.9K.
- HCA Healthcare made up 0.07% of Eaton Vance Management's portfolio in Q3 2022, its #269 holding.
- Eaton Vance Management first reported a position in HCA Healthcare in Q4 2013 and has held it in 36 quarters since.
- Eaton Vance Management's HCA Healthcare position peaked at $66.8M in Q1 2022.
- 867 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.